Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_assertion description "[The most frequent adverse events were acneiform dermatitis (18 [60%] patients with NRAS -mutated melanoma and 15 [37%] patients with the BRAF-mutated melanoma), rash (six [20%] and 16 [39%]), peripheral oedema (ten [33%] and 14 [34%]), facial oedema (nine [30%] and seven [17%]), diarrhoea (eight [27%] and 15 [37%]), and creatine phosphokinase increases (11 [37%] and nine [22%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_assertion evidence source_evidence_literature NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_assertion SIO_000772 23414587 NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_assertion wasDerivedFrom befree-2016 NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_assertion wasGeneratedBy ECO_0000203 NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1053422.RAijxo0D6T6YmNvaIWj4AodxJE2mQmXM_byyz4sitVMvs130_provenance.